Cargando…
IRAK signalling in cancer
Innate immune signalling has an essential role in inflammation, and the dysregulation of signalling components of this pathway is increasingly being recognised as an important mediator in cancer initiation and progression. In some malignancies, dysregulation of inflammatory toll-like receptor (TLR)...
Autores principales: | Rhyasen, G W, Starczynowski, D T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453441/ https://www.ncbi.nlm.nih.gov/pubmed/25290089 http://dx.doi.org/10.1038/bjc.2014.513 |
Ejemplares similares
-
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
por: Bennett, Joshua, et al.
Publicado: (2022) -
IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014) -
Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014) -
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML
por: Bennett, Joshua, et al.
Publicado: (2023) -
IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival
por: Adams, Allie K., et al.
Publicado: (2015)